Month: September 2021

How to VoteHow to VoteVANCOUVER, British Columbia, Sept. 28, 2021 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT, OTCQX: KNTNF ) is pleased to announce it has mailed the Notice of Meeting and Management Information Circular to shareholders of record as of September 20, 2021 in connection with the Annual General and Special Meeting to be held virtually on Thursday, October 28, 2021, at 2:00 p.m. (Pacific Time). Due to the impacts of Covid-19 pandemic, governmental recommendations and/or orders for physical distancing, restrictions on group gatherings, non-essential travel and business activities, we request that shareholders do not attend the meeting in person. Health and safety is a paramount value at K92 and to mitigate any risks to stakeholder, employees, partners and community members...

Ribbon Cutting to be Led by Patient Advocacy Organizations, Caregivers, and Key Stakeholders Largest and First Centralized, Scalable, State-of-the-Art Facility with the Potential to Manufacture TIL Cell Therapies for Thousands of Cancer Patients Annually SAN CARLOS, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), is celebrating the official opening of the Iovance Cell Therapy Center (iCTC). The iCTC, located at the Philadelphia Navy Yard, is the first centralized, scalable, state-of-the-art manufacturing facility dedicated to producing TIL cell therapies for patients with solid tumor cancers. The current capacity is expected to...

Caledon, Ontario, Sept. 28, 2021 (GLOBE NEWSWIRE) — CardioGenics Holdings INC. (OTC PINK: CGNH) announced on September 3, 2021 a record date of September 13, 2021 for its dividend distribution of 22.5 million shares of Covidgenic, a private Canadian company. The new record date for the distribution of the Covidgenic shares will be October 8th, 2021. Any further updated will be posted at www.cardiogenics.com. Please forward any questions regarding the dividends to info@cardiogenics.com About CardioGenics Holdings Inc. The Company is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary point-of-care immuno-analyzer, which will be capable of running 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests....

GUADALAJARA, Mexico, Sept. 28, 2021 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (the “Company” or “GAP”) announces that today it has made a capital stock reduction payment of Ps. 7.80 (SEVEN PESOS 80/100 M.N.) per outstanding share representing the Company’s shareholder equity, to the institution S.D. INDEVAL, S.A. de C.V. for distribution to shareholders, according to the record date of September 27, 2021. This capital stock reduction payment corresponds to the thirty-one such payment. The capital stock reduction payment was approved at the Extraordinary Shareholders’ Meeting held on September 14, 2021.    Company Description: Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico’s Pacific region, including the major cities of Guadalajara and...

BRENTWOOD, Tenn, Sept. 28, 2021 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, has been invited to present at the Fall Harvest – Best Ideas from the Buy-Side conference, which is being held virtually starting October 5, 2021. IMAC CEO Jeff Ervin is scheduled to present on Tuesday, October 5 at 11:30 ET. Management will be available for one-on-one meetings to be held throughout the conference. Investors can register here. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.goertz@issuerdirect.com. About the Fall Harvest – Best Ideas from the Buy-Side Conference The Fall Harvest...

TORONTO, Sept. 28, 2021 (GLOBE NEWSWIRE) — (TSXV: TVC) Three Valley Copper Corp. (“Three Valley Copper” or the “Company”) is pleased to provide a corporate and operating update on its 91.1% owned Minera Tres Valles (“MTV”) property near Salamanca, Region de Coquimbo, Chile. Papomono Masivo Block Caving Underground Construction and Resulting Preliminary Guidance Construction began on this project in December 2020. Papomono Masivo (“PPM”) has proven and probable reserves of approximately 102 million pounds of contained copper with an average grade of 1.51%4. The development of PPM currently is at 71% for horizontal works and 85% for vertical works and the Company’s continued expectation is that PPM will be completed end of 2021/early 2022 with the planned ramp-up of production during 2022. “We continue to improve the development...

CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior leadership plans to present at the following conferences in October. Scientific conferences:Event: AACR: Tumor Immunology and Immunotherapy – DetailsTopic: GEN-011: A neoantigen-targeted peripheral blood-derived T cell therapy that has broad neoantigen specificity and high T cell purity while avoiding pro-tumor cellsFormat: Poster presentationDate: Tuesday-Wednesday, October 5-6thTime: Available throughout the conferenceEvent: Meeting on the Mesa – DetailsTopic: Next-generation neoantigen-targeted solid tumor T cell therapyFormat: PresentationDate: Tuesday-Thursday, October 12-14thTime: Available throughout...